4.8 Article

LUBAC-Recruited CYLD and A20 Regulate Gene Activation and Cell Death by Exerting Opposing Effects on Linear Ubiquitin in Signaling Complexes

期刊

CELL REPORTS
卷 13, 期 10, 页码 2258-2272

出版社

CELL PRESS
DOI: 10.1016/j.celrep.2015.11.009

关键词

-

资金

  1. BRC [294880]
  2. Welton Foundation
  3. Cancer Research UK-UCL Centre
  4. Wellcome Trust [096831/Z/11/Z]
  5. BBSRC CASE studentship [BB/J013129/1]
  6. MRC
  7. Wellcome Trust [096831/Z/11/A] Funding Source: Wellcome Trust
  8. Biotechnology and Biological Sciences Research Council [1319955] Funding Source: researchfish
  9. Medical Research Council [MC_U117565398] Funding Source: researchfish
  10. The Francis Crick Institute [10142] Funding Source: researchfish
  11. Wellcome Trust [096831/Z/11/A] Funding Source: researchfish
  12. MRC [MC_U117565398] Funding Source: UKRI

向作者/读者索取更多资源

Ubiquitination and deubiquitination are crucial for assembly and disassembly of signaling complexes. LUBAC-generated linear (M1) ubiquitin is important for signaling via various immune receptors. We show here that the deubiquitinases CYLD and A20, but not OTULIN, are recruited to the TNFR1- and NOD2-associated signaling complexes (TNF-RSC and NOD2-SC), at which they cooperate to limit gene activation. Whereas CYLD recruitment depends on its interaction with LUBAC, but not on LUBAC's M1-chain-forming capacity, A20 recruitment requires this activity. Intriguingly, CYLD and A20 exert opposing effects on M1 chain stability in the TNF-RSC and NOD2-SC. While CYLD cleaves M1 chains, and thereby sensitizes cells to TNF-induced death, A20 binding to them prevents their removal and, consequently, inhibits cell death. Thus, CYLD and A20 cooperatively restrict gene activation and regulate cell death via their respective activities on M1 chains. Hence, the interplay between LUBAC, M1-ubiquitin, CYLD, and A20 is central for physiological signaling through innate immune receptors.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据